Search for other papers by Linda M. Thienpont in
Google Scholar
PubMed
Search for other papers by Katleen Van Uytfanghe in
Google Scholar
PubMed
Search for other papers by Sofie Van Houcke in
Google Scholar
PubMed
Search for other papers by Barnali Das in
Google Scholar
PubMed
Search for other papers by James D. Faix in
Google Scholar
PubMed
Search for other papers by Finlay MacKenzie in
Google Scholar
PubMed
Search for other papers by Frank A. Quinn in
Google Scholar
PubMed
Search for other papers by Michael Rottmann in
Google Scholar
PubMed
Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
laboratory tests include lipids, HbA1c, creatinine, and enzymes [ 4 , 5 , 6 , 7 ], but more are under development [ 8 , 9 , 10 , 11 ]. The IFCC Committee for Standardization of Thyroid Function Tests (C-STFT) aims at equivalence of laboratory testing for
Search for other papers by Federica D’Aurizio in
Google Scholar
PubMed
Search for other papers by Alessia Biasotto in
Google Scholar
PubMed
Search for other papers by Claudia Cipri in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Jessica Zucco in
Google Scholar
PubMed
Search for other papers by Stefania Marzinotto in
Google Scholar
PubMed
Department of Medicine, University of Udine, Udine, Italy
Search for other papers by Francesco Curcio in
Google Scholar
PubMed
Search for other papers by Salvatore Benvenga in
Google Scholar
PubMed
Established facts Thyroid function tests (TFT) are the most commonly requested endocrine tests in both inpatient and outpatient settings. Constant interaction among the clinician, the laboratory and the manufacturer is of paramount
Search for other papers by Rajesh Rajput in
Google Scholar
PubMed
Search for other papers by Vaibhav Pathak in
Google Scholar
PubMed
switched to weekly LT4 therapy it increased to 3.9 ± 1.1 mIU/L ( p ≤ 0.001) (Table 2 ). Table 1. Baseline characteristics of study groups I and II Table 2. Intragroup comparison of thyroid function test of group I and group II at
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
this focused review, we discuss the continuum of maternal thyroid function test abnormalities in pregnancy. Specifically, we describe the assessment of maternal thyroid function in pregnancy, the management of overt and subclinical thyroid disease, and
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
sporadic Graves' disease and genomic activating mutations in the TSH receptor of the neonate [ 1 ]. Despite the clinical thyrotoxicosis of the patient, thyroid function tests are important tools in diagnosing hyperthyroidism. The results of the tests are
Search for other papers by Zohar Steinberg Ben-Zeev in
Google Scholar
PubMed
Search for other papers by Marina Peniakov in
Google Scholar
PubMed
Search for other papers by Clari Felszer in
Google Scholar
PubMed
Search for other papers by Scott A Weiner in
Google Scholar
PubMed
Search for other papers by Avishay Lahad in
Google Scholar
PubMed
Search for other papers by Shlomo Almashanu in
Google Scholar
PubMed
The Rappaport Faculty of Medicine, Technion, Institute of Technology, Haifa, Israel
Search for other papers by Yardena Tenenbaum Rakover in
Google Scholar
PubMed
primary congenital hypothyroidism (CH) ( 17 , 18 ). The potential effects of maternal thyroid disease on offspring have led to the clinical practice of recommending serum thyroid function tests (TFT), including free T4 (FT4) and TSH, in infants born to
Institute of Public Health, University of Copenhagen
Search for other papers by Torquil Watt in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
National Research Centre for the Working Environment, Copenhagen
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Department of Palliative Medicine, Bispebjerg Hospital
Search for other papers by Mogens Groenvold in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
and cubed values. To test the stability of the results, several post hoc analyses were performed. In the univariate pairwise analyses of the relationship between QoL scales and thyroid function, the latter was also operationalized as (a) current
Search for other papers by Theodora Pappa in
Google Scholar
PubMed
Department of Endocrinology, Metabolism and Diabetes, Evgenideion Hospital, Athens University School of Medicine, Athens, Greece
Search for other papers by Maria Alevizaki in
Google Scholar
PubMed
alternative. Furthermore, the increased prevalence of hypothyroidism in patients with DM is another factor illustrating the clinical relevance of metformin's effect on thyroid function tests [ 6 ]. In addition, various reports have linked metformin use with
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
axis leading to changes in thyroid function tests overlapping with the abnormalities seen in primary thyroid disease. A special area of practical concern is the common complaint from patients treated for thyroid disease that therapy has led to
Search for other papers by Mahdi Kamoun in
Google Scholar
PubMed
Search for other papers by Michèle d'Herbomez in
Google Scholar
PubMed
Search for other papers by Christine Lemaire in
Google Scholar
PubMed
Search for other papers by Armelle Fayard in
Google Scholar
PubMed
Search for other papers by Rachel Desailloud in
Google Scholar
PubMed
Search for other papers by Damien Huglo in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
thyrotoxicosis recurred 2 months later, and the patient was referred to our university department. Thyroid function tests after immuno-precipitation were as follow: FT3 10.3 pmol/l; FT4 48.3 pmol/l, and TSH 5.4 µU/ml. Serum concentration of the α-TSH was elevated